Semin Vasc Med 2005; 5(2): 87-97
DOI: 10.1055/s-2005-872395
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001 USA.

Folate Metabolism and Cardiovascular Disease

Yvo M. Smulders1 , Coen D. A. Stehouwer2
  • 1Department of Internal Medicine, VU University Medical Center, Amsterdam
  • 2Department of Internal Medicine, University Hospital Maastricht and Maastricht University, Maastricht, The Netherlands
Further Information

Publication History

Publication Date:
27 July 2005 (online)

ABSTRACT

Folate is a water-soluble vitamin that occurs in different chemical forms distinguished by their oxidation state and the specific type of one-carbon substitution. Folates occur in natural food sources as reduced methylated or formylated tetrahydrofolate. Folic acid is a synthetic analogue with no metabolic activity of its own. Pharmacological doses of folic acid cause it to appear in plasma, where it has unknown, but potentially adverse, effects. This review discusses folate absorption, body distribution, and intracellular folate metabolism. The main physiological functions of folate can be classified as methylation and DNA synthesis. Several mechanisms act in concert to regulate the folate metabolic pathways to ensure that both functions of folate are fulfilled properly. B-vitamin deficiencies and genetic polymorphisms (particularly the C677T mutation in the methylenetetrahydrofolatereductase gene) have multiple effects on folate metabolism. Impairment of the methylation cycle, for example, leads to hyperhomocysteinemia, a proposed atherothrombotic factor. However, methylation disturbances also result in hypomethylation of DNA and other molecules, which may also contribute to the pathogenesis of cardiovascular disease. As cardiovascular researchers, we should try to develop a more integrative view on folate metabolism, rather than focusing merely on hyperhomocysteinemia.

REFERENCES

  • 1 Wills L. Treatment of pernicious anaemia of pregnancy and tropical anaemia with special reference to yeast extract as curative agent.  BMJ. 1931;  1 1059-1064
  • 2 Scott J, Weir D. Folate/vitamin B12 interrelationships.  Essays Biochem. 1994;  28 63-72
  • 3 Mason J B, Rosenberg I H. Intestinal absorption of folate. In: Johnson LR Physiology of the Gastrointestinal Tract New York; Raven Press 1994: 1979-1995
  • 4 Seyoum E, Selhub J. Properties of food folates determined by stability and susceptibility to intestinal pteroylpolyglutamate hydrolase action.  J Nutr. 1998;  128 1956-1960
  • 5 Lin Y, Dueker S R, Follett J R et al.. Quantitation of in vivo human folate metabolism.  Am J Clin Nutr. 2004;  80 680-691
  • 6 Naughton C A, Chandler C J, Duplantier R B, Halsted C H. Folate absorption in alcoholic pigs: in vitro hydrolysis and transport at the intestinal brush border membrane.  Am J Clin Nutr. 1989;  50 1436-1441
  • 7 Selhub J, Dhar G J, Rosenberg I H. Gastrointestinal absorption of folates and antifolates.  Pharmacol Ther. 1983;  20 397-418
  • 8 Wright A J, Finglas P M, Dainty J R et al.. Single oral doses of 13C forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: potential problems in interpretation of folate bioavailability studies.  Br J Nutr. 2003;  90 363-371
  • 9 Selhub J, Brin H, Grossowicz N. Uptake and reduction of radioactive folate by everted sacs of rat small intestine.  Eur J Biochem. 1973;  33 433-438
  • 10 Kelly P, McPartlin J, Goggins M, Weir D G, Scott J M. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements.  Am J Clin Nutr. 1997;  65 1790-1795
  • 11 Gregory III J F, Williamson J, Bailey L B, Toth J P. Urinary excretion of [2H4]folate by nonpregnant women following a single oral dose of [2H4]folic acid is a functional index of folate nutritional status.  J Nutr. 1998;  128 1907-1912
  • 12 Henderson G B. Folate-binding proteins.  Annu Rev Nutr. 1990;  10 319-335
  • 13 Lucock M. Is folic acid the ultimate functional food component for disease prevention?.  BMJ. 2004;  328 211-214
  • 14 Ross J, Green J, Baugh C M, MacKenzie R E, Matthews R G. Studies on the polyglutamate specificity of methylenetetrahydrofolate dehydrogenase from pig liver.  Biochemistry. 1984;  23 1796-1801
  • 15 Rao K N. Pteroyl- and tetrahydropteroylpolyglutamate effects on the catalytic activity of thymidylate synthase from lactobacillus leichmannii: a novel method for determining gamma-glutamyl chain lengths of the folylpolyglutamates.  Indian J Biochem Biophys. 1994;  31 184-190
  • 16 Pfeiffer C M, Fazili Z, McCoy L, Zhang M, Gunter E W. Determination of folate vitamers in human serum by stable-isotope-dilution tandem mass spectrometry and comparison with radioassay and microbiologic assay.  Clin Chem. 2004;  50 423-432
  • 17 Sirotnak F M, Tolner B. Carrier-mediated membrane transport of folates in mammalian cells.  Annu Rev Nutr. 1999;  19 91-122
  • 18 Antony A C. Folate receptors.  Annu Rev Nutr. 1996;  16 501-521
  • 19 Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes.  Mol Genet Metab. 2000;  71 121-138
  • 20 Scott J M. Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry.  J Cardiovasc Risk. 1998;  5 223-227
  • 21 Scott J M. Folate and vitamin B12.  Proc Nutr Soc. 1999;  58 441-448
  • 22 Cook J D, Cichowicz D J, George S, Lawler A, Shane B. Mammalian folylpoly-gamma-glutamate synthetase. 4. In vitro and in vivo metabolism of folates and analogues and regulation of folate homeostasis.  Biochemistry. 1987;  26 530-539
  • 23 Bertino J R, Coward J K, Cashmore A et al.. Polyglutamate forms of folate: natural occurrence and role as substrates in mammalial cells.  Biochem Soc Trans. 1976;  4 853-856
  • 24 Matthews R G, Ghose C, Green J M, Matthews K D, Dunlap R B. Folylpolyglutamates as substrates and inhibitors of folate-dependent enzymes.  Adv Enzyme Regul. 1987;  26 157-171
  • 25 Gregory J F, Cuskelly G J, Shane B, Toth J P, Baumgartner T B, Stacpoole P W. Primed, constant infusion with [2H3]serine allows in vivo kinetic measurement of serine turnover, homocysteine remethylation, and transsulphuration processes in human one-carbon metabolism.  Am J Clin Nutr. 2000;  72 1535-1541
  • 26 Finkelstein J D. Methionine metabolism in mammals.  J Nutr Biochem. 1990;  1 228-237
  • 27 MacCoss M J, Fukagawa N K, Matthews D E. Measurement of intracellular sulfur amino acid metabolism in humans.  Am J Physiol Endocrinol Metab. 2001;  280 E947-E955
  • 28 Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW Homocysteine in Health and Disease Cambridge; Cambridge University Press 2001: 63-78
  • 29 Eden S, Cedar H. Role of DNA methylation in the regulation of transcription.  Curr Opin Genet Dev. 1994;  4 255-259
  • 30 Clarke S. Protein methylation.  Curr Opin Cell Biol. 1993;  5 977-983
  • 31 Kutzbach C, Stokstad E L. Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by S-adenosylmethionine.  Biochim Biophys Acta. 1971;  250 459-477
  • 32 Wagner C, Briggs W T, Cook R J. Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism.  Biochem Biophys Res Commun. 1985;  127 746-752
  • 33 Stover P, Schirch V. 5-Formyltetrahydrofolate polyglutamates are slow tight binding inhibitors of serine hydroxymethyltransferase.  J Biol Chem. 1991;  266 1543-1550
  • 34 Stover P, Schirch V. Serine hydroxymethyltransferase catalyzes the hydrolysis of 5,10- methenyltetrahydrofolate to 5-formyltetrahydrofolate.  J Biol Chem. 1990;  265 14227-14233
  • 35 Matthews R G, Baugh C M. Interactions of pig liver methylenetetrahydrofolate reductase with methylenetetrahydropteroylpolyglutamate substrates and with dihydropteroylpolyglutamate inhibitors.  Biochemistry. 1980;  19 2040-2045
  • 36 Cuskelly G J, Stacpoole P W, Williamson J, Baumgartner T G, Gregory III J F. Deficiencies of folate and vitamin B6 exert distinct effects on homocysteine, serine, and methionine kinetics.  Am J Physiol Endocrinol Metab. 2001;  281 E1182-E1190
  • 37 Miller J W, Nadeau M R, Smith J, Smith D, Selhub J. Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism.  Biochem J. 1994;  298(Pt 2) 415-419
  • 38 Selhub J, Miller J. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine.  Am J Clin Nutr. 1992;  55 131-138
  • 39 Scott J M, Weir D G. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia.  Lancet. 1981;  2 337-340
  • 40 Carmel R, Melnyk S, James S J. Cobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism.  Blood. 2003;  101 3302-3308
  • 41 Chanarin I. The Megaloblastic Anaemias . Oxford: Blackwell Scientific Publishing 1979
  • 42 Jones III C W, Priest D G. Interaction of pyridoxal 5-phosphate with apo-serine hydroxymethyltransferase.  Biochim Biophys Acta. 1978;  526 369-374
  • 43 Shane B. Folate chemistry and metabolism. In: Bailey LB Folate in Health and Disease New York; Marcel Dekker 1995: 1-22
  • 44 Martinez M, Cuskelly G J, Williamson J, Toth J P, Gregory III J F. Vitamin B-6 deficiency in rats reduces hepatic serine hydroxymethyltransferase and cystathionine {beta}-synthase activities and rates of in vivo protein turnover, homocysteine remethylation and transsulfuration.  J Nutr. 2000;  130 1115-1123
  • 45 Kang S S, Zhou J, Wong P W, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.  Am J Hum Genet. 1988;  43 414-421
  • 46 Schneider J A, Rees D C, Liu Y T, Clegg J B. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation.  Am J Hum Genet. 1998;  62 1258-1260
  • 47 Jacques P F, Bostom A G, Williams R R et al.. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.  Circulation. 1996;  93 7-9
  • 48 Klerk M, Verhoef P, Clarke R et al.. MTHFR 677C->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA.  JAMA. 2002;  288 2023-2031
  • 49 Jacques P F, Kalmbach R, Bagley P J et al.. The relationship between riboflavin and plasma total homocysteine in the Framingham offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.  J Nutr. 2002;  132 283-288
  • 50 McNulty H, McKinley M C, Wilson B et al.. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements.  Am J Clin Nutr. 2002;  76 436-441
  • 51 Bagley P J, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells.  Proc Natl Acad Sci U S A. 1998;  95 13217-13220
  • 52 Friso S, Choi S W, Girelli D et al.. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status.  Proc Natl Acad Sci U S A. 2002;  99 5606-5611
  • 53 Choi S W, Friso S, Ghandour H, Bagley P J, Selhub J, Mason J B. Vitamin B-12 deficiency induces anomalies of base substitution and methylation in the DNA of rat colonic epithelium.  J Nutr. 2004;  134 750-755
  • 54 Jacob R A, Gretz D M, Taylor P C et al.. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women.  J Nutr. 1998;  128 1204-1212
  • 55 Rampersaud G C. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women.  Am J Clin Nutr. 2000;  72 998-1003
  • 56 Fu W, Dudman N PB, Perry M A, Young K, Wang X L. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.  Biochem Biophys Res Commun. 2000;  271 47-53
  • 57 Yi P, Melnyk S, Pogribna M, Pogribny I P, Hine R J, James S J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation.  J Biol Chem. 2000;  275 29318-29323
  • 58 Lee M E, Wang H. Homocysteine and hypomethylation: a novel link to vascular disease.  Trends Cardiovasc Med. 1999;  9 49-54
  • 59 Chen P, Poddar R, Tipa E V et al.. Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease.  Adv Enzyme Regul. 1999;  39 93-109
  • 60 James S J, Melnyk S, Pogribna M, Pogribny I P, Caudill M A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology.  J Nutr. 2002;  132 2361S-2366S
  • 61 Andreassi M G, Botto N. DNA damage as a new emerging risk factor in atherosclerosis.  Trends Cardiovasc Med. 2003;  13 270-275
  • 62 Andreassi M G, Botto N, Cocci F et al.. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.  Hum Genet. 2003;  112 171-177
  • 63 Castro R, Rivera I, Struys E A et al.. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease.  Clin Chem. 2003;  49 1292-1296
  • 64 Chen Z, Karaplis A C, Ackerman S L et al.. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition.  Hum Mol Genet. 2001;  10 433-443
  • 65 Hiltunen M O, Turunen M P, Hakkinen T P et al.. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions.  Vasc Med. 2002;  7 5-11
  • 66 Laukkanen M O, Mannermaa S, Hiltunen M O et al.. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene.  Arterioscler Thromb Vasc Biol. 1999;  19 2171-2178
  • 67 Lund G, Andersson L, Lauria M et al.. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E.  J Biol Chem. 2004;  279 29147-29154
  • 68 Dong C, Yoon W, Goldschmidt-Clermont P J. DNA methylation and atherosclerosis.  J Nutr. 2002;  132 2406S-2409S
  • 69 Weber D J, McFadden P N. Injury-induced enzymatic methylation of aging collagen in the extracellular matrix of blood vessels.  J Protein Chem. 1997;  16 269-281
  • 70 Duthie S J, Narayanan S, Brand G M, Pirie L, Grant G. Impact of folate deficiency on DNA stability.  J Nutr. 2002;  132 2444S-2449S
  • 71 Narayanan S, McConnell J, Little J et al.. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo.  Cancer Epidemiol Biomarkers Prev. 2004;  13 1436-1443
  • 72 Cwikiel M, Eskilsson J, Albertsson M, Stavenow L. The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture.  Ann Oncol. 1996;  7 731-737

Yvo M SmuldersM.D. 

Department of Internal Medicine, VU University Medical Center, P.O. Box 7057

1007 MB Amsterdam, The Netherlands

    >